| Condition | Indicated | Relationship Strength | Studies | Trials |
|---|
Libman-Sacks Disease
[description not available] | 0 | 8.68 | 16 | 3 |
Lupus Erythematosus, Systemic
A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. | 0 | 8.68 | 16 | 3 |
Degenerative Diseases, Central Nervous System
[description not available] | 0 | 3.06 | 1 | 0 |
Central Nervous System Disease
[description not available] | 0 | 3.06 | 1 | 0 |
Innate Inflammatory Response
[description not available] | 0 | 3.06 | 1 | 0 |
Peripheral Nerve Diseases
[description not available] | 0 | 3.06 | 1 | 0 |
Central Nervous System Diseases
Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord. | 0 | 3.06 | 1 | 0 |
Inflammation
A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. | 0 | 3.06 | 1 | 0 |
Peripheral Nervous System Diseases
Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves. | 0 | 3.06 | 1 | 0 |
Neurodegenerative Diseases
Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures. | 0 | 3.06 | 1 | 0 |
Disease Models, Animal
Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. | 0 | 6.48 | 6 | 1 |
Sicca Syndrome
[description not available] | 0 | 2.17 | 1 | 0 |
Sjogren's Syndrome
Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis. | 0 | 2.17 | 1 | 0 |
Disease Exacerbation
[description not available] | 0 | 2.17 | 1 | 0 |
Protein Folding Diseases
[description not available] | 0 | 2.17 | 1 | 0 |
Allergic Neuritis, Experimental
[description not available] | 0 | 2.17 | 1 | 0 |
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
[description not available] | 0 | 2.17 | 1 | 0 |
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
A slowly progressive autoimmune demyelinating disease of peripheral nerves and nerve roots. Clinical manifestations include weakness and sensory loss in the extremities and enlargement of peripheral nerves. The course may be relapsing-remitting or demonstrate a step-wise progression. Protein is usually elevated in the spinal fluid and cranial nerves are typically spared. GUILLAIN-BARRE SYNDROME features a relatively rapid progression of disease which distinguishes it from this condition. (Adams et al., Principles of Neurology, 6th ed, p1337) | 0 | 2.17 | 1 | 0 |
Autoimmune Disease
[description not available] | 0 | 2.99 | 1 | 0 |
Autoimmune Diseases
Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. | 0 | 2.99 | 1 | 0 |